PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
20-Sep-2022 Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab Tiziana Life Sciences
20-Sep-2022 Genomic data start-up opens global headquarters Zetta Genomics
20-Sep-2022 GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process GenScript
20-Sep-2022 Synaffix Wins ‘Best ADC Platform Technology’ Award Again at World ADC Awards Ceremony 2022 Synaffix
20-Sep-2022 Immutep Clinical Development Update for its First-in-Class LAG-3 Antigen Presenting Cell Activator Candidate Eftilagimod Alpha Immutep
20-Sep-2022 Minoryx‘s marketing authorization application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked adrenoleukodystrophy (X-ALD) Minoryx
20-Sep-2022 Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders Coave Therapeutics
20-Sep-2022 Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma Andrew Lloyd Associates
20-Sep-2022 Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma Andrew Lloyd Associates
20-Sep-2022 Rapid growth puts Australian CRO Accelagen on the map for clinical research globally Accelagen
16-Sep-2022 Alfa Chemistry Offers High-Quality Dexmedetomidine Hydrochloride Meeting CP & EP Standards Alfa Chemistry
15-Sep-2022 Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference Novotech Health Holdings Pte Ltd
15-Sep-2022 Tridek-One closes a €16 million financing round to develop first-in-class immune checkpoint agonists Andrew Lloyd Associates
15-Sep-2022 TRIDEK-ONE CLOSES A €16 MILLION FINANCING ROUND TO DEVELOP FIRST-IN-CLASS IMMUNE CHECKPOINT AGONISTS Andrew Lloyd Associates
14-Sep-2022 Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022 Ayala Pharmaceuticals
13-Sep-2022 ValitaCell Joins Beckman Coulter Life Sciences Beckman Coulter Life Sciences
13-Sep-2022 Ori Biotech and CTMC partner to accelerate novel cell therapy delivery Ori Biotech
13-Sep-2022 Ciliatech presents groundbreaking concept in glaucoma implants, first to bypass opening anterior eye chamber Andrew Lloyd Associates
13-Sep-2022 Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals Bora Pharmaceuticals
13-Sep-2022 Alfa Chemistry Newly Releases Biological Stains for Laboratory and Diagnostic Use Alfa Chemistry